Using language nudges and a medication-preference app to boost shared decision-making and self-care in type 2 diabetes
Effect of Nudge-Based Shared Decision Making on Self-Management Among Patients With Type 2 Diabetes: A Randomized Controlled Trial
NA · Xiamen University · NCT07129915
This trial will test whether training doctors to use short language 'nudges' plus a mobile app for recording medication preferences helps adults with type 2 diabetes make treatment choices and stick to their medicines.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 250 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Xiamen University (other) |
| Locations | 1 site (Xiamen, Fujian) |
| Trial ID | NCT07129915 on ClinicalTrials.gov |
What this trial studies
In this randomized trial 250 adults with type 2 diabetes at Xiang'an Hospital will be assigned to an intervention or usual-care group and followed for six months. Clinicians in the intervention arm receive training in linguistic nudging to encourage shared decision-making, while patients use a mobile app to record medication preferences that clinicians can view and incorporate. The control group receives standard diabetes care without the training or preference app. Primary outcomes include medication adherence, frequency of blood glucose monitoring, and measures of glycemic control.
Who should consider this trial
Good fit: Adults aged 18 or older with confirmed type 2 diabetes, normal cognitive function, basic smartphone/WeChat ability, and willingness to give informed consent are ideal candidates.
Not a fit: Patients with severe acute diabetic complications, documented cognitive impairment, inability to use a smartphone/WeChat, current participation in other trials, pregnancy/lactation, or life expectancy under six months are unlikely to benefit from this program.
Why it matters
Potential benefit: If successful, the approach could improve medication adherence, increase glucose self-monitoring, and lead to better blood sugar control by aligning clinician advice with patient preferences.
How similar studies have performed: Previous studies combining clinician communication techniques and mobile preference tools have shown modest gains in adherence and decision quality, but results are mixed and data specific to Chinese T2D populations are limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Confirmed diagnosis of type 2 diabetes * Age ≥ 18 years * Normal cognitive function (assessed by Mini-Cog score ≥ 3) * Basic smartphone operation ability (can independently use WeChat) * Willing to participate and sign informed consent Exclusion Criteria: * Severe acute complications (e.g., ketoacidosis, hyperosmolar coma) * Documented cognitive impairment (dementia, Alzheimer's, etc.) * Currently participating in other clinical trials * Life expectancy \< 6 months * Pregnancy or lactation
Where this trial is running
Xiamen, Fujian
- Xiang'an Hospital Affiliated to Xiamen University — Xiamen, Fujian, China (RECRUITING)
Study contacts
- Study coordinator: Wei WANG, M.D.
- Email: wwei19742007@hotmail.com
- Phone: +8613939809540
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Diabetes Mellitus, Type 2, Physician-Patient Relations, Self-management, Linguistic Nudging, Shared Decision Making, Randomized Controlled Trial, Mobile Health Application, Chinese Population